Literature DB >> 3968120

The effect of age on bone composition and viability in the femoral head.

S Y Wong, J Kariks, R A Evans, C R Dunstan, E Hills.   

Abstract

We studied the effect of age on bone composition and osteocyte viability in femoral heads from fifty-one subjects. The assessment included determination of: bone volume, ash weight, calcium, and phosphorus content; osteocyte viability in fresh sections stained for lactate dehydrogenase activity; microfractures in fresh sections after removal of marrow elements; bone area, the presence of metabolic bone disease, and the histology of microfractures in embedded calcified sections; and the extent of trabecular microfractures. Bone area and numbers of microfractures were also assessed in eight elderly hip-fracture patients. Bone volume decreased with age, but there was considerable variation in each age group, and no significant difference between men and women. Ash weight and the bone content of calcium and phosphorus also decreased with age, but were constant if corrected for bone volume. Almost all osteocytes were viable in subjects who were younger than twenty-five years, and thereafter viability progressively decreased to a mean of 74 per cent in the eighth decade of life. There was a significant negative correlation between osteocyte viability and age. There was no evidence of metabolic bone disease in any patient. The numbers of microfractures increased with age and correlated negatively with bone viability (r = -0.31, p less than 0.05); in simple linear correlation a relationship between bone area and microfractures could not be demonstrated but in multiple linear correlation, after the inclusion of bone viability, there was an additional negative correlation between numbers of microfractures and bone area (p less than 0.005). Bone area and numbers of microfractures in hip-fracture patients were similar to those in age-matched controls.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968120

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  13 in total

1.  Osteocyte viability with glucocorticoid treatment: relation to histomorphometry.

Authors:  P N Sambrook; D R Hughes; A E Nelson; B G Robinson; R S Mason
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

2.  Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-catenin.

Authors:  K Jähn; N Lara-Castillo; L Brotto; C L Mo; M L Johnson; M Brotto; L F Bonewald
Journal:  Eur Cell Mater       Date:  2012-09-12       Impact factor: 3.942

3.  Bone histology in young adult osteoporosis.

Authors:  E Hills; C R Dunstan; S Y Wong; R A Evans
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

4.  Cancellous bone in human acetabulum: microradiographic and histomorphometric aspects.

Authors:  C Nyssen-Behets; L Fabeck; C Denis; A Dhem
Journal:  Arch Orthop Trauma Surg       Date:  1995       Impact factor: 3.067

Review 5.  Osteocyte death and hip fracture.

Authors:  C R Dunstan; N M Somers; R A Evans
Journal:  Calcif Tissue Int       Date:  1993       Impact factor: 4.333

6.  Bone death in hip fracture in the elderly.

Authors:  C R Dunstan; R A Evans; E Hills; S Y Wong; R J Higgs
Journal:  Calcif Tissue Int       Date:  1990-11       Impact factor: 4.333

Review 7.  Bone quality: a determinant for certain risk factors for bone fragility.

Authors:  C M Schnitzler
Journal:  Calcif Tissue Int       Date:  1993       Impact factor: 4.333

Review 8.  Trabecular microfracture.

Authors:  N L Fazzalari
Journal:  Calcif Tissue Int       Date:  1993       Impact factor: 4.333

Review 9.  Remodeling and the repair of fatigue damage.

Authors:  D B Burr
Journal:  Calcif Tissue Int       Date:  1993       Impact factor: 4.333

10.  An animal model of femoral head osteonecrosis induced by a single injection of absolute alcohol: an experimental study.

Authors:  Zhen-Hong Zhu; You-Shui Gao; Shi-Hua Luo; Bing-Fang Zeng; Chang-Qing Zhang
Journal:  Med Sci Monit       Date:  2011-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.